# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-25-020627
Filing Date
2025-11-03
Accepted
2025-11-03 17:09:59
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | formdefa14a.htm | DEFA14A | 27978
2 | GRAPHIC | formdefa14a_001.jpg | GRAPHIC | 464515
3 | GRAPHIC | formdefa14a_002.jpg | GRAPHIC | 230213
4 | GRAPHIC | formdefa14a_003.jpg | GRAPHIC | 519264
5 | GRAPHIC | formdefa14a_004.jpg | GRAPHIC | 309421
| Complete submission text file | 0001493152-25-020627.txt |  | 2127708

Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39555 | Film No.: 251445152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)